Clinical trial
Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine…
NCT00185380 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185380 |
|---|---|
| Title | Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS) |
| Official title | Multi-center, Open, Randomized, Dose Finding Phase II Study to Investigate Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) Releasing Different Amounts of Levonorgestrel Compared to MIRENA in Nulliparous and Parous Women in Need of Contraception. |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Levonorgestrel IUS (BAY86-5028, G04209B), G04209C), Levonorgestrel IUS (Mirena, BAY86-5028) |
| Enrollment | 742 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 10, 2015 |
| Countries | Finland, Hungary, Norway, Sweden, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: